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filopodia-induced zippering in prostate cancer
Alejandra V Paez1, Carla Pallavicini2, Federico Schuster1, Maria Pia Valacco1, Jimena Giudice3, Emiliano G Ortiz1, Nicolás Anselmino1,
Estefania Labanca4, Maria Binaghi1, Marcelo Salierno1, Marcelo A Martí1, Javier H Cotignola1, Anna Woloszynska-Read5,
Luciana Bruno2, Valeria Levi1, Nora Navone4, Elba S Vazquez1 and Geraldine Gueron*,1
Prostate cancer (PCa) cells display abnormal expression of cytoskeletal proteins resulting in an augmented capacity to resist
chemotherapy and colonize distant organs. We have previously shown that heme oxygenase 1 (HO-1) is implicated in cell
morphology regulation in PCa. Here, through a multi 'omics' approach we define the HO-1 interactome in PCa, identifying HO-1
molecular partners associated with the integrity of the cellular cytoskeleton. The bioinformatics screening for these cytoskeletal-
related partners reveal that they are highly misregulated in prostate adenocarcinoma compared with normal prostate tissue. Under
HO-1 induction, PCa cells present reduced frequency in migration events, trajectory and cell velocity and, a significant higher
proportion of filopodia-like protrusions favoring zippering among neighboring cells. Moreover forced expression of HO-1 was also
capable of altering cell protrusions in transwell co-culture systems of PCa cells with MC3T3 cells (pre-osteoblastic cell line).
Accordingly, these effects were reversed under siHO. Transcriptomics profiling evidenced significant modulation of key markers
related to cell adhesion and cell–cell communication under HO-1 induction. The integration from our omics-based research
provides a four molecular pathway foundation (ANXA2/HMGA1/POU3F1; NFRSF13/GSN; TMOD3/RAI14/VWF; and PLAT/PLAU)
behind HO-1 regulation of tumor cytoskeletal cell compartments. The complementary proteomics and transcriptomics approaches
presented here promise to move us closer to unravel the molecular framework underpinning HO-1 involvement in the modulation
of cytoskeleton pathways, pushing toward a less aggressive phenotype in PCa.
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Prostate cancer (PCa) is the most frequently diagnosed
cancer in men aside from skin cancer.1 Although PCa has
been well defined in regards to the mutational landscape,
analysis at the proteome level of these genetic alterations is
still understudied. Most of the functional information of the
cancer-associated genes relies in the proteome, an excep-
tionally complex biological system involving several proteins
that function through dynamic protein–protein interactions and
post-translational modifications.2
Tumor development and progression are partly conse-
quence of defects in mechanisms controlling cytoskeletal
remodeling.3 Actin re-arrangement and attachment to focal
adhesions at the leading edge of a migrating cell, generate the
driving force necessary for movement.3 The loss of cell–cell
adhesion enables cancer cells to dissociate from the primary
tumor mass and changes in cell–matrix interaction allows the
cells to invade the surrounding stroma.4 Higher grade prostate
carcinoma has been associated with the loss of cell adhesion
molecules at adherens junctions.5 Cell protrusive forces are
partly regulated by theGTP-binding protein Rac.6 The delicate
equilibrium between the cell pushing and pulling forces drive
leading edge dynamics and cell migration. Interdigitating
filopodia are vital for the proper alignment and establishment
of the initial cell–cell adhesions7 This event is known as
adhesion 'zippering'.8
Heme oxygenase 1 (HO-1) is the rate-limiting enzyme in
heme degradation.9,10 HO-1 is as a stress response protein
and a critical mediator of cellular homeostasis.11 Although the
role of HO-1 in cancer is controversial,12 we have shown that
its pharmacologic or genetic upregulation is associated with a
less aggressive phenotype in PCa.13 HO-1 inhibits cell
proliferation, migration and invasion,14 it impairs tumor growth
and angiogenesis in vivo and downregulates the expression
of target genes associated with inflammation.14,15 HO-1 is
also implicated in the modulation of cellular adhesion in
PCa, upregulating E-cadherin and β-catenin expression, and
relocating them to the cell membrane,13 favoring a more
epithelial phenotype. However, it is yet unclear which are the
HO-1 interactors and how it regulates cytoskeleton
organization.
In this work, we undertook a proteomics study to build the
HO-1 interactome in PCa. We showed that HO-1 binds to key
factors associated with the dynamics of the actin cytoskeleton
and induces the remodeling of the actin filament architecture
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at filopodia. Further we obtained RNA-sequencing (RNA-Seq)
profiles and determined a significant alteration of cytoskeletal
genes by HO-1 induction, establishing molecular pathways by
which forced expression of HO-1 leads to amore adhesive and
less invasive phenotype, further supporting the antitumoral
function in PCa.
Results
Proteomics profiling of HO-1-interacting proteins in PCa
cells. We have previously demonstrated HO-1 implications
on the maintenance of the epithelial cell morphology and
architecture.13 We hypothesized that HO-1 could be exerting
a regulatory role through its interaction with cytoskeleton-
associated proteins. For this purpose, we conducted an in-
depth mass spectrometry-based proteomics study. We
constructed a recombinant FLAGHO-1 protein. PC3 cells
were transiently transfected with FLAGHO-1 or the respective
controls and treated with H2O2. Immunoprecipitated protein
complexes were subjected to LC-ESI MS/MS (Figure 1a).
This approach rendered a list of 56 proteins (Table 1). We
performed a protein interaction network, showing intercon-
nectivity either by reported gene colocalization, genetic
interactions, predicted functional relationship, shared protein
domains or physical interaction (Figure 1b, right panel). In all,
53% of the HO-1 interactome showed physical interconnec-
tivity. The gene ontology (GO) analysis revealed an enrich-
ment of proteins associated with four main functions: DNA
and chromatin, RNA metabolism (post-transcription, includ-
ing splicing), actin and cytoskeleton proteins and other
proteins (Figure 1b, left panel).
Crystallographic analysis of HO-1-interacting proteins.
To assess protein domain interaction of HO-1 interactors, we
obtained their reference amino-acid sequences. The crystal-
lographies with the highest coverage and score were
selected and introduced into the protein domain database
(PFAM) (Supplementary Figure S1). Using the inferred
domain–domain interactions, we restricted the analysis to
those proteins presenting domain interconnectivity, obtaining
a network with 28 nodes and 29 edges (Figure 1d). We could
not predict domain interaction between HO-1 and its inter-
actome because HO-1 is a small globular protein with only
one reported domain. However, we successfully predicted
domain interactions among several HO-1-interacting pro-
teins: LASP1 and TES through the LIM domain, TES and
ARNTL2 through LIM and HLH domains and TRIM28 and
SRP20 through PHD and RMM_1, (Figure 1d). The crystal-
lographic analysis of protein domains further supports
physical interconnectivity of HO-1 interactor proteins.
Analysis of multiple microarray data sets for cytoskeletal
HO-1-interacting proteins. Given that HO-1 modulates
the cell adhesive properties and morphology,13 we focused
on HO-1-interacting proteins associated with the cytoskeleton
organization. To address their relevance in PCa, we searched
the public cancer microarray database, Oncomine
(http://www.oncomine.org) (Figure 2a). The expression profile
for these genes showed significant dysregulation for most of
the cytoskeletal interactors of HO-1, in particular, upregula-
tion for TMOD3, TOP1, CBX3, RCC1, NPM1 and down-
regulation for ANXA2, HSPB1, STAT3 and TES (fold change
⩾1.5, P-value⩽ 0.05; Figure 2b). The meta-analysis combin-
ing data from the independent data sets showed that the
above-mentioned dysregulated cytoskeletal genes for pros-
tate adenocarcinoma versus normal prostate gland lie within
the 25% of the most consistently high- or low-expressed
genes across this comparison. Of note, TES and MKLN lie
within the 1–9% of the lowest expressed genes in PCa versus
normal tissue (Figure 2b).
We also used the cBioPortal for Cancer Genomics
platform (www.cbioportal.org) to search for the most common
genetic alterations for these cytoskeletal proteins in PCa
(Figure 2c, left panel). Results show presence of muta-
tions, amplifications and deletions for the cluster of cyto-
skeletal genes selected. Of note, amplification was the
most frequent alteration across the data sets (Figure 2c,
right panel).
PCa cell 2-D migratory patterns under forced expression
of HO-1. To examine whether the association of HO-1 with
proteins implicated in the integrity of the actin cytoskeleton
had an impact on PCa cellular migratory trajectories, we
evaluated quantitatively the motion of cells in a wound-
healing assay. Cells were treated with hemin (specific inducer
of HO-1, 80 μM, 24 h). A linear scratch was done along
the culture plate and cells were imaged using phase contrast
Figure 1 Construction of the HO-1 interactome in PCa cells. (a) Simplified schematic workflow of the construction of the HO-1 interactome in PC3 cells. FLAGHO-1
immunoprecipitation assays were performed from PC3 cell extracts that had been previously transiently transfected with FLAGHO-1 plasmid or empty FLAG vector and treated
with H2O2 (200 μM, 1 h). For LC-ESI MS/MS analyses, peptides were desalted and concentrated using a C18 resin. Peptides were analyzed by reverse-phase chromatography
before mass spectrometry analysis. The peak lists obtained were processed and analyzed with NCBI databases using Mascot Software (Matrix Science Inc, Boston, MA, USA)
and compared with the human genome, with a fragment ion mass tolerance of 0.80 Da and a parent ion tolerance of 2.0 Da. (b) Protein interaction network of HO-1 interactome in
PC3 cells displaying interconnectivity either by reported gene colocalization, genetic interactions, predicted functional relationship, shared protein domains or physical interaction
(left panel). Protein interaction network shows physical interconnectivity between HO-1-interacting proteins (right panel). (c) GO analysis of HO-1-interacting proteins was
performed using DAVID software (https://david.ncifcrf.gov/). The resulting categories for biological process, cellular components and molecular functions were further sub-
clustered into four global categories named: 'DNA and chromatin' (red), 'RNA processing' (blue), 'actin and cytoskeleton' (yellow) and 'other function' (green). (d) Schematic
representation of the inferred domain–domain interactions of HO-1-interacting proteins. Reference amino-acid sequences of protein domains of HO-1 interactors were aligned
against the Protein Data Bank (PDB). The crystallographies with the highest coverage and score were selected and introduced into the protein domain database (PFAM). HO-1
candidate interactors protein domains were annotated. Individual searches in the Interaction Protein Family (iPfam) database were performed. The networks were built using
Cytoscape 3.2.1 software showing 201 nodes (rectangles) and 327 edges (black lines). The interactome network (framed in orange dashed-line, upper panel) was simplified and
consists of 28 nodes (circles) and 29 edges (black lines) (bottom panel) representing: yellow circles, domains of HO-1-interacting proteins; red circles, HO-1-interacting proteins;
light blue circles, other protein domains interacting with domains of HO-1-interacting proteins
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microscopy at 1 frame/20 min during 48 h. Single-cell
trajectories (Figure 3a) were analyzed to obtain the mean
squared displacement (MSD) versus time plot in each
experimental condition. Figure 3b shows that the MSD
obtained in both conditions increases as a function of time;
however, after 10 h, the MSD obtained in hemin-treated cells
was significantly smaller than in control cells. HO-1 induction
significantly reduces the area explored by PCa cells in the
assayed temporal window compared with control cells.
PCa cellular protrusions under HO-1 induction. To
analyze whether there were variations in cell–cell interac-
tions, we determined the distribution of the distances to the
first neighboring cell under HO-1 modulation (Figure 3c). For
every cell or cell cluster, we calculated the distance to all the
other cells/cell clusters (white line) and to the first neighboring
cell (red line) (Figure 3c). Results show that HO-1 induction in
PC3 cells significantly reduced the distances to the first
neighboring cell (Po0.05; Figure 3d).
Table 1 List of HO-1-interacting proteins identified by MS/MS analysis
Protein name Gene
symbol
Theroretical molecular
mass (Da)
No. of
peptides
Coverage %
High mobility group protein HMG-I/HMG-Y isoform a AHCTF1 11 669 2 29.2
Alpha-2-HS-glycoprotein AHSG 39 193 5 25
Anexin 2 ANXA2 38 808 3 13.6
Cycle-like factor CLIF ARNTL2 67 908 1 2
Aspartyl beta-hydroxylase ASPH 85 959 1 3
Potassium-transporting ATPase alpha chain 1 ATP4A 114 045 1 2
Putative uncharacterized protein C5orf27 C5ORF27 10 849 1 14.58
Chromobox homolog 1 CBX1 21 519 2 11.2
Chromobox homolog 3 CBX3 20 997 2 15.2
Coiled-coil domain-containing protein 73 CCDC73 1079 1 2.78
Cardiomyopathy-associated protein 5 CMYA5 17 545 1 0.9
Damage-specific DNA-binding protein 1, 127kDa DDB1 128 086 1 1.4
Translation elongation factor 1-alpha EEF1A1 35 825 2 12
Eukaryotic translation elongation factor 2 EEF2 96 246 1 2.9
Translation initiation factor eIF3 p40 subunit EIF3H 40 075 1 5
FtsJ3 protein FTSJ3 84 015 1 2
Gelsolin GSN 31 052 3 22.7
High mobility group AT-hook 1 HMGA1 34 635 1 5.1
Heme oxygenase 1 HO-1 32 798 5 25
Heat shock 27 kDa protein HSPB1 22 427 3 31.4
Junctional sarcoplasmic reticulum protein 1 JSRP1 36 296 1 2
KH-type splicing regulatory protein KHSRP 10 362 1 24.4
Lasp-1 LASP1 30 185 1 5
Matrin 3 MATR3 95 078 2 5
Multiple epidermal growth factor-like domains protein 10 MEGF10 122 121 1 2.11
Muskelin 1 MKLN1 84 713 11 17
Kinesin-like protein KIF23 MKLP-1 98 842 1 1.7
Interferon-induced Mx protein MX1 75 929 1 2
Nucleosome assembly protein 1-like 1 NAP1L1 45 631 1 4.1
Nitric oxide-associated protein NOA1 78 409 1 4.44
Nucleophosmin 1 NPM1 3109 2 12.7
5´-Nucleotidase, cytosolic II NT5C2 65 384 1 2
Palmdelphin, isoform CRA_a PALMD 53 404 1 2
Programmed cell death 5 short isoform PDCD5 4472 1 32
Peroxiredoxin 2 PDX2 22 014 1 5
Purine-rich element binding protein A PURA 35 003 1 8.2
Retinoic acid-induced 14 RAI14 110 617 1 1.5
Regulator of chromosome condensation RCC1 44 485 1 3.7
Replication protein A 70 kDa DNA-binding subunit RPA1 68 723 1 3.6
Ribosomal protein SA pseudogene 9 RPSA1 32 947 1 9
s100 calcium- binding protein A6 S100A6BP 1023 1 8
Splicing factor, arginine/serine-rich 3 SFRS3 19 546 1 11.8
Signal-induced proliferation-associated 1-like protein 1 SIPA1L1 201 102 1 1.25
K-Cl co-transporter KCC4 SLC12A7 120 327 1 0.6
Isoform 4 of Spastin SPAST 54 385 1 7.23
Spermatogenesis-associated protein 7 SPATA7 8799 1 36.84
Sequestosome 1 SQSTM1 4837 1 4.5
RNA polymerase II transcription factor SIII subunit A3-like-2 TCEB3CL2 59 735 1 3.48
Testis-derived transcript TES 49 789 1 3.1
Thyroid hormone receptor-associated protein 3 THRAP3 108 686 1 1.9
Mitochondrial import inner membrane translocase subunit TIMM44 15 215 1 19.55
Tropomodulin 3 TMOD3 39 727 2 9.7
DNA topoisomerase 1 TOP1 66 890 2 5.3
Tripartite motif-containing 28 TRIM28 80 621 6 18
Zinc-finger CCCH-type, antiviral 1 ZC3HAV1 103 135 3 7.3
Zinc-finger protein 589 ZNF589 40 736 7 36
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We used confocal microscopy to study the changes in the
cytoskeletal organization, in particular the cell adhesion
zippering through the actin stress fibers at the leading edge
level of PCa cells. To quantify contacts among cells, we
selected regions in which the filopodia from two neighboring
cells touched each other, considered as 'contacts', and divided
these regions into segments where the distance between the
cells remained constant (Figures 3e and f). An intensity profile
for each of these areas was analyzed with a custom made
algorithm to count contacts (Figure 3e). A 'contact density'was
defined for each region as the ratio between the number
of contacts and the length of the profile. Results showed an
increased contact density under HO-1 induction, favoring
adhesion zippering (Figure 3g; Po0.05). Filopodia-like
protrusions (cell filopodia density) were also enhanced by
hemin treatment (Figure 3h; Po0.05).
Using a specific siRNA for HO-1 (siHO-1), the effects
observed on the augmented filopodia per cell and cell–cell
contact, under HO-1 induction, were reversed (Figure 4a, left
panel). Efficiency of HO-1 depletion was confirmed bywestern
blot (Figure 4a, right panel). Accordingly cell zippering under
HO-1 induction, was also impaired (Figure 4b). Contacts were
further analyzed for the different distances among cells (range
1–25 μm), displaying no negative correlation between cell–cell
contacts and distance between cells for all treatments
(Figure 4c). Moreover, HO-1 silencing also reverted the
augmented filopodia density after hemin exposure (Figure 4d).
Presence of HO-1 at the leading edge protrusions of cells
was also assayed by immunofluorescence. HO-1 induction in
PC3 showed increased expression of this protein in the
cytoplasm and nuclei of cells but did not reveal localization at
cell filopodia (Supplementary Figure S2).
Metastatic cells rely on invadopodia to degrade and invade
ECM.5 To rule out that these increased protrusions were
invadopodia structures, we stained cells for metalloproteinase
9 (MMP9), a metalloproteinase highly implicated in tumor
invasion. No staining for MMP9 was detected at these
protrusions (Supplementary Figure S3).
Microtubule mechanics in PC3 cells treated or not with
hemin was also evaluated by confocal microscopy (Supple-
mentary Figure S4). The persistence length (pL) of micro-
tubules was measured in PC3 cells. A Fourier analysis was
performed and the ensemble variance of Fourier amplitudes
was calculated. Both, cells treated or not with hemin, exhibited
a similar thermal-like q-dependence: (1/Lp*)*(1/q)2 with no
variation of Lp (Supplementary Figure S4).
Considering that PC3 cells present an osteolytic bone
metastatic behavior, we extended our observations to C4-2B
cells, another PCa cell line with osteoblastic metastatic
behavior. Imaging of C4-2B cells also revealed an increased
network of filopodia from neighboring cells and an augmented
number of protrusions per cell by forced expression of HO-1
(Supplementary Figure S5). HO-1 depletion could revert the
increased contact density under hemin exposure (Supple-
mentary Figure S5), however, no significant difference was
observed in the filopodia density, probably due to a reduced
efficiency of the siHO compared with the effect observed in
PC3 cells. These results show that HO-1 induction in PCa cells
favors a more adhesive phenotype regardless the bone
metastatic behavior.
Analysis of PCa cellular protrusions in the presence of
CM from co-culture systems (PC3 and MC3T3). As bone
is the most common and frequent site of PCa progression
and the bioinformatics analysis has shown important dys-
regulation of cytoskeletal proteins in the metastatic stage
of PCa, we next assessed the effect of conditioned media
(CM) obtained from transwell co-culture systems (PC3 and
MC3T3), on tumoral cell protrusions. MC3T3 is an osteoblast
precursor cell line derived from mouse calvaria.16
PC3 cells pre-treated or not with hemin were co-cultured
with or without MC3T3 cells. CM from the different experi-
mental protocols was then added to PC3 cells (Figure 5a). Cell
contact density and number of protrusions were evaluated by
confocal microscopy (Figure 5b). Regarding contacts between
cells, no correlation was observed for contact density and cell–
cell distance for all conditions (Figure 5c). CM from co-culture
systems reduced the number of contacts among PCa cells
(Figure 5d; PC3+CM2 versus PC3+CM1) and hemin pre-
treatment prevented this fall (Figure 5d; PC3+CM4 versus
PC3+CM2). Intriguingly, the CM from co-culture systems
impacted negatively on the membrane filopodia density of
PC3 cells (Figure 5d; PC3+CM2 versus PC3+CM1). These
effects were prevented by hemin pre-treatment (Figure 5d;
PC3+CM4 versus PC3+CM2). These findings suggest that
induced HO-1 expression in PC3 cells alters the soluble
factors released to the CM in the co-culture systems, in turn
affecting cell filopodia and zippering. A more adhesive
phenotype of tumoral cells potentially prevent them from
extravasation and invasion of other homing organs.
Analysis of RNAseq data on PCa cells overexpressing
HO-1 pharmacologically or genetically. Given the sound
cellular evidence of HO-1 modulation on PCa cell adhesive-
ness and protrusive forces, we carried out an RNA-Seq
analysis to compare gene expression profiles between PCa
cells overexpressing HO-1 pharmacologically (hemin treat-
ment) or genetically (transfected with pcDNA3HO-1) and their
respective controls (Figure 6a). For both comparisons:
PC3HO-1 versus PC3pcDNA3 (empty vector) and PC3
hemin versus PC3 control we obtained differential subsets
of upregulated (⩾2, ⩾ 3, ⩾5, ⩾8-fold change cut-off) and
downregulated (⩽−2, ⩽−3, ⩽−5, ⩽− 8-fold change cut-off)
genes (Figure 6b). We screened for overlapping up or
downregulated genes for both comparisons (on same thresh-
old subsets). Results show 92 downregulated (⩽−2,
Po0.05) and 118 upregulated (⩾2, Po0.05) overlapping
genes (Figure 6b). We selected these overlapping gene data
sets and performed GO analysis identifying pathways
in which these differentially expressed genes are involved
and enriched in subcategories (Figure 6c). We performed
a second heat map depicting the top 37 significantly
regulated genes within these cytoskeletal-related cate-
gories (Figure 6d), highlighting key markers related to cell
adhesion (blue) and cell–cell communication (light blue).
We also built a transcriptomic interaction network, between
the GO overlapping twofold upregulated gene cate-
gories (red) and twofold downregulated gene categories
(blue) showing interconnectivity either by reported genetic
interactions, common pathways, or physical interactions
(Figure 6e).
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Integrated analysis of HO-1 transcriptomic and proteo-
mics data in PCa. We next integrated the transcriptomic
overlapping data sets with the HO-1 interactome for a
combined holistic view of HO-1 molecular mechanisms
implicated in the cytoskeletal remodeling in PCa. Figure 7a
shows the interaction network between the cytoskeletal GO
categories of the proteome with the overlapping twofold
upregulated gene categories (red) and twofold downregu-
lated gene categories (blue) of the trascriptome.
Filtering by physical interconnectivity among these data
sets, four main molecular pathways were depicted: ANXA2
(Annexin 2) connected to PLAU (urokinase-type plasminogen
activator precursor) signaling axis, HMGA1 (high mobility
group AT-Hook) connecting to POU3F1, (POU class 3
homeobox 1) GSN (Gelsolin) with TNFRSF13C (tumor
necrosis factor receptor superfamily member 13C) and
TMOD3 (tropomodulin 3) and RAI1 (retinoic acid induced 1)
with VWF (VonWillebrand factor) (Figure 7b, left panel). These
pathways are intrinsically related to the cytoskeleton remodel-
ing, MMP secretion, uPA pathways, Rho GTPases pathway
and filopodia and lamillopodia regulation (Figure 7b, right
panel). This network creates a molecular framework by which
HO-1 operates at the molecular level governing cell protrusive
forces, migration, invasion and cell adhesiveness.
Interestingly, uPA/uPAR, through the activation of the
plasminogen system, degrade ECM, and consequently drive
tumor cell membrane protrusion and motility.17 The RNAseq
profiling for both PCa cells overexpressing HO-1 pharmacolo-
gically or genetically showed a direct regulation of the critical
factors in the uPA/uPARcascade, such as the downregulation of
the axis activators: uPA/uPAR (PLAU/PLAUR) and tPA (PLAT),
and the upregulation of the axis inhibitors: CPB2 (thrombin
activator of fibrinolysis inhibitor), SERPINF2 (alpha 2 anti-
plasmin, and F12 (factor XIIA). Our data delineate a molecular
axis by which HO-1 potentially shuts down the acquisition of an
invasive tumor cell phenotype, crucial for cancer metastasis.
Discussion
Different sets of genes, proteins and metabolites govern
progression from a precursor lesion, to the localized disease
and finally to the metastatic stage. Although several studies
have profiled PCa tissues at the transcriptome level, less work
has been done at the protein level that serve as the functional
effectors of cancer progression.
Several studies have shown the anti-inflammatory effects of
HO-1 on diseases 18–20 although the underlying mechanisms
are still to be deciphered. Its role in cancer is still
controversial.12,21–25 In PCa, HO-1 impairs cell proliferation,
migration invasion, and angiogenesis in vitro and in vivo.14
The confirmation of its association with the augmented
adhesive capabilities of cells and the induction and relocation
of E-cadherin and β-catenin to the cell membrane,13 led us to
hypothesize its potential implications in cell–cell adhesion
zippering and in the regulation of the actin dynamics at the
leading edge of cells.
For this purpose, we built for the first time the HO-1
interactome in PCa cells, showcasing 56 molecular partners,
including cytoskeletal proteins with roles in cell structure,
physiological processes, cell signaling and regulation of the
actin stress fiber dynamics. Pharmacological HO-1 induction
altered migratory patterns and PCa cell trajectories toward a
less motile phenotype.
Cell–cell adhesion is essential for the development,
differentiation and maintenance of tissues. Epithelial cells
require cell–cell adhesion zippering to promote barrier
function.8 This barrier is critical in the maintenance of cellular
homeostasis. Its loss provides a considerable advantage for
carcinoma progression, as disruption of cell–cell interactions
and detachment from the ECM are required for proliferation,
aberrant signaling, epithelial-to-mesenchymal transition, inva-
sion and metastasis.7 These events are facilitated by the actin
cytoskeleton and tubulin at microtubules.26 Actin is the key
component of several cellular structures, including filopodia,
lamellipodia and stress fibers. Actin bundling contributes to
epithelial cell polarity by preserving cell–cell junctions and
microvilli.26 In the metastatic disorder, actin and the cytoske-
letal proteins serve as mechanosensors between the cell and
the microenvironment.26 There is no general rule whether
actin bundling promotes or inhibits cancer metastasis.26
Mechanical stiffness has long been positively associated with
invasion and metastasis.27 However, Swaminathan et al.28
reported that cancer cells with the highest migratory and
invasive potential are significantly less stiff than cells with the
lowest migratory and invasive potential. It is clear that
transformed cells display corrupt actin bundling, turning the
cytoskeletal compartment into a key target to understand
tumor progression and develop appropriate therapies.
By confocal microscopy, we quantified and compared actin
filaments at the leading edge level in PCa cells. HO-1 induced
the remodeling of the actin filament architecture at filopodia,
yielding a more adhesive and less invasive phenotype. The
fact that HO-1 silencing could revert the augmented contact
density observed under HO-1 forced expression, showcases
a direct effect on cellular actin-based protrusions. However,
HO-1 displays negative staining at cell filopodia, pointing to a
regulatory role of this protein on the actin filaments, rather than
a direct interaction between these proteins.
Figure 2 Meta-analysis of multiple microarray data sets for cytoskeletal HO-1-interacting proteins. (a) Expression microarray studies selected from the Oncomine platform
(http://www. oncomine. org) comparing prostate adenocarcinoma versus normal prostate. (b) Summary table showing the gene name, median gene rank and corresponding
P-value for the HO-1 cytoskeleton-related interacting proteins. The median rank for a gene is the rank for the gene across each of the analyses. The P-value for a gene is the P-
value for the median ranked analysis. Right panel shows a heat map indicating the level of expression for each gene in each study selected (blue: least expressed, red: most
expressed). Each square represents the number of studies that met our eligibility criteria and thresholds. Colors are z-score normalized to depict relative values within a row. (c)
Studies selected from the cBioPortal for Cancer Genomics platform (www.cbioportal.org) summarizing the total number of cases with alterations for each study (left panel). The
graph (right panel) shows the percentage of altered cases (y axis) and the alteration type observed whether it corresponds to mutations or copy number alterations (CNA) for each
study (x axis). Mutations are shown in green, deletions in blue, amplifications in red and multiple alterations in gray, for the cytoskeleton-related proteins mentioned in (b) across
the seven data sets selected comparing prostate tumor tissue versus normal prostate
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Men with PCa display characteristically osteoblastic bone
metastases, which are the main cause of morbidity and
mortality of the disease.29 A previous report has shown HO-1
potentiality in modifying the bone microenvironment and
subsequent PCa metastases.30 To explore the contribution
of HO-1 in the interaction between PCa cells and osteoblasts,
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we used co-culture systems (PC3 and MC3T3). PCa cells
exposed to CM from these co-culture systems, displayed
reducedmembrane filopodia density and contact among cells,
effects reverted by hemin pre-treatment. Retraction of cell
protrusions could be a sign of rounding up of cells and may be
one of the characteristic features of cell detachment. Our
results suggest that HO-1 prevents PCa cells from extravasa-
tion and invasion to other homing organs.
To point out the significance of the cytoskeletal HO-1-
interacting proteins in prostate carcinogenesis, we searched
the public cancer microarray database Oncomine and
cBioportal. Essential transcriptional features for lethal
castration-resistant PCa were discovered using meta-
analysis of transcriptomic data.31,32 Interestingly, TES and
MKLN lie within the 1–9% of the lowest expressed genes
across this comparison. TES, a scaffold protein that partici-
pates in the reorganization of the actin cytoskeleton,33 is
known for being a tumor suppressor in PCa.34 MKLN1, a
nucleocytoplasmic mediator of cellular morphology and
adhesiveness,35 exhibits similar sub-cellular dynamics to
HO-1, relocating from the cell membrane toward the cell
nuclei under hemin treatment.13
Multi 'omics' technologies reveal new aspects of the
mechanistic strategy that HO-1 uses to alter protrusive forces
and adhesiveness of tumor cells, which may not otherwise be
deduced from a single-omics approach. The RNA profiling
evidenced significant alterations of key markers related to cell
adhesion and cell–cell communication under HO-1 induction.
Strikingly, when integrating the transcriptome under HO-1
modulation with the HO-1 interactome, a framework of four
main molecular pathways arose as the foundation for the
regulation of the tumor cell protrusive forces: ANXA2/HMGA1/
POU3F1; NFRSF13/GSN; TMOD3/RAI14/VWF; PLAT/PLAU.
We provide a schematic representation of the different
cytoskeletal-associated targets modulated by HO-1 over-
expression, which is supported by the results presented here
and our previous data.13,14 Of note, downregulation of uPA/
uPAR directly impacts on Rho GTPases pathways through the
alpha V-Beta 3 integrin receptor, which in turn affect filopodia
formation. HO-1 binds Gelsolin, STAT3 and HSPB1, poten-
tially supporting its implication in filopodia regulation and gives
ground to HO-1 involvement at the molecular level in the
modulation of the cytoskeleton pathways.
Materials and Methods
Cell culture, treatments, reagents and antibodies. PC3 cells were
obtained from the American Type Culture Collection (Manassas, VA, USA) and were
routinely cultured in RPMI 1640 (Invitrogen, Grand Island, NY, USA) supplemented
with 10% fetal bovine serum (FBS). PC3 cells were transiently transfected with
HO-1FLAG plasmid or FLAG empty vector.
Hemin was obtained from Sigma-Aldrich (Glasgow, UK). For treatments, cells were
incubated 24 h in RPMI media containing 10% FBS and then were exposed to hemin
(80 μM, 24 h).
For H2O2 treatment, cells were exposed to H2O2 (200 μM, 0.5 h).
Polyclonal and monoclonal anti-HO-1 antibodies were from Stressgen Biotechnol-
ogies Corp. (San Diego, CA, USA). Anti-β-actin antibody was purchased from Sigma-
Aldrich (UK). The rhodamine–phalloidin was purchased from Life Technologies
(Thermo Fisher Scientific Inc., Eugene, OR, USA). Anti-mouse and anti-rabbit
secondary antibodies conjugated with HRP were from Amersham Ltd (Freiberg,
Germany). Secondary antibodies conjugated with Alexa Fluor 488 or Alexa Fluor 555
were from Molecular Probes, Invitrogen (Grand Island, NY, USA).
p3xFLAG-CMV-10-HO-1 cloning. p3xFLAG-CMV-10-HO-1 vector was
generated by cloning the cDNA sequence encoding the human HO-1 (HMOX1)
into the restriction sites EcoRI and BamHI of the mammalian expression vector
p3xFLAG-CMV-10 (Sigma-Aldrich, UK). This strategy results in the fusion of the
Flag tag peptide at the C-terminus of the HMOX1. The sequences of the primers
used were as follow: forward – 5′-GCAGAATTCAGAGCGTCCGCAACCC-3′;
reverse – 5′- GCCGGATCCGCATTCACATGGCATAAAGC-3′.
FLAG immunoprecipitation strategy. PC3 cells were transfected either
with FLAGHO-1 plasmid or the empty vector as a control. Forty-eight hours after
transfection, proteins were extracted using a buffer with a low NaCl concentration
(20 mM Tris, 150 mM NaCl, 5 mM MgCl2, 0.5% NP40, pH 7,5) not to disrupt the
protein–protein interactions. Protein extracts were incubated with Flag Magnetic
Beads (purchased from Sigma-Aldrich, UK) for 2 h at 4 °C. After removing the
proteins that did not interact with the FLAG construction, the proteins complexes
formed were incubated with 3XFLAG peptide (100 μg/μl) for 2 h at 4 °C. Flag
peptide competes with the proteins complexes bound to the magnetic beads and, as
a consequence, the FLAGHO-1-interacting proteins remain in the supernatant.
Separation of peptides and mass spectrometry. Recombinant
FLAGHO-1 protein complexes were reduced (200 mM DTT), alkylated (200 mM
iodoacetamide) and digested with trypsin in-solution overnight, using an estimated
1 : 30 enzyme to substrate ratio. The peptides were desalted and concentrated in a
C18 resin (Zip-Tips, Waters Technologies Corporation, Milford, MA, USA) before
analysis by LC-ESI MSMS at the Center for Metabolomics and Mass Spectrometry
(The Scripps Research Institute, La Jolla, CA, USA). Peptides were separated by
reverse-phase chromatography before mass spectrometry analysis using the
following method: nanoelectrospray capillary column tips were made in-house by
using a P-100 laser puller (Sutter Instruments, Novato, CA, USA). The columns
were packed with Zorbax SB-C18 stationary phase (Agilent Technologies, Santa
Clara, CA, USA) purchased in bulk (5-mm particles, with a 15-cm length and a
Figure 3 HO-1 overexpression impairs cellular trajectories in PCa cell lines and modulates the filopodia-like protrusions among neighboring PCa cells. Control and hemin
(80μM, 24 h) treated PC3 cells were grown to confluence into a monolayer in 35 mm Petri dishes. A linear scratch wound was done along the culture plate and cell movement was
monitored at a rate of 1 frame/20 min. (a) Representative cell trajectory plots obtained for control (left panel) or hemin-treated PC3 cells (right panel). Red dashed circles
represent the mean area explored by PC3 cells after 1100 min. (b) Trajectories were analyzed to obtain the MSD (mean square displacement) plot for control or hemin-treated
cells. Data represent the average MSD± standard error over time, obtained from the analysis of 78 and 70 trajectories of control and hemin-treated cells, respectively. (c) PC3
cells treated with hemin (80 μM, 24 h) or vehicle (control) were fixed and stained with C-Laurdan and images of large fields containing several cells were acquired using a 10x
objective in an Olympus Wide Field Microscope (left panel). The images were analyzed with an algorithm designed to binnarize the image and assign a label to each set of
connected pixels. In the right panel, each color represents a different cell or cell cluster (orange dotted circles). For every cell or cell cluster, the distances to all the other cells/cell
clusters (white lines) and to the first neighboring cell (red line) were calculated. Distances were normalized to the average cell radii. (d) The distribution of the distances to the first
neighbor cell was plotted for control and hemin-treated PC3 cells. The x axis displays the cell–cell distances (using a representative cell radius as scale) and the y axis represents
the corresponding probability amplitude (N⩾ 2200 first neighbor distances for each condition). (e) PC3 cells treated with hemin or vehicle (control) were fixed and stained with
rhodamine–phalloidin. Cells were imaged by confocal microscopy. The regions, in which cell filopodia contacted two neighboring cells, were divided into segments where the
distance between the cells remained constant (blue frame). An intensity profile (yellow line) for each of these sectors was determined using a custom made algorithm to count
contacts (Matlab). Arrow heads represent the intensity peaks considered as filopodia. (f) Two representative images for each group are shown (scale bars: 10 μm). White open
boxes represent the zoomed images (scale bars: 2 μm). (g) Boxplot comparing the cell–cell contact density for the different experimental conditions. (h) The individual cell
filopodia density was measured in hemin-treated and control cells (N⩾ 91 for each condition). *Significant difference, Po0.001
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75-mm inner diameter). The reverse-phase gradient separation was performed by
using water and acetonitrile (0.1% formic acid) as the mobile phases. The gradient
consisted of 5% acetonitrile for 10 min followed by a gradient to 8% acetonitrile for
5 min, 35% acetonitrile for 113 min, 55% acetonitrile for 12 min, 95% acetonitrile for
15 min and re-equilibrated with 5% acetonitrile for 15 min.
Data-dependent MS/MS data were obtained with an LTQ linear ion trap mass
spectrometer using a home-built nanoelectrospray source at 2 kV at the tip. One MS
spectrum was followed by 4 MS/MS scans on the most abundant ions after the
application of a dynamic exclusion list. Tandem mass spectra were extracted by use of
Xcalibur software (Thermo Scientific, Waltham, MA, USA). All MS/MS samples were
analyzed by using Mascot (version 2.1.04; Matrix Science, London, UK) with H. Sapiens
proteins contained in the NCBI protein database, assuming the digestion enzyme
trypsin. Mascot was searched with a fragment ion mass tolerance of 0.80 Da and a
parent ion tolerance of 2.0 Da; identification was done at the 95% confidence level with a
Figure 4 Filopodia-like protrusions under HO-1 modulation using siHO-1. (a) PC3 cells were treated with hemin (80 μM, 24 h) or vehicle (control) and transfected with a
specific siRNA for HO-1 (siHO-1) or scrambled siRNA (control). Cells were fixed and stained with rhodamine–phalloidin and imaged by confocal microscopy. One representative
image for each group is shown (left panel). Efficiency of siHO-1 was confirmed by western blot. β-Actin was used as loading control (right panel). (b) Cell–cell contact density
versus cell–cell distance. The amount of contacts between cells was obtained and a linear density was determined by computing the number of contacts per unit perpendicular
distance. Each data point represents the mean contact density within a bin determined by Freedman–Diaconis rule and error bars represent standard error of the mean (N⩾ 33
contact regions for each condition). *Significant difference, Po0.001. (c) Boxplot comparing the cell–cell contact density versus cell distance for the different experimental
conditions. The regions, in which cell filopodia contacted two neighboring cells, were divided into segments where the distance between the cells remained constant. An intensity
profile for each of these sectors was determined using a custom-made algorithm to count contacts (Matlab) (N⩾ 33 contact regions for each condition; *Po0.001). (d) Boxplot
comparing filopodia density on single cells for the different experimental conditions. The density was measured by scanning an intensity profile around the cell perimeter and
evaluating the amount of filopodia per unit length (N⩾ 19 cells for each condition; *significant difference, Po0.001)
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calculated false-positive rate ofo1% as determined by using a reversed concatenated
protein database. Peptide identifications were accepted if they could be established at a
495.0% probability as specified by thePeptide Prophet algorithm. Protein identifications
were accepted if they could be established at a499.0% probability and contained at
least two identified peptides as specified by the Protein Prophet algorithm.36 Proteins that
contained similar peptides and could not be differentiated based on MS/MS analysis
alone were grouped to satisfy the principles of parsimony. To control for nonspecific
binding, we compared FLAGHO-1 co-purifying proteins with those immunoprecipitated in
cells transfected with a FLAG empty vector. Only differential FLAGHO-1 binding proteins
compared with FLAG-binding proteins were considered further.
Bioinformatics data analysis. In all cases, the networks were performed
using Cytoscape 3.2.1 software (Institute of Systems Biology, Seattle, USA). GO
analysis was performed using the Database for Annotation, Visualization and
Integrated Discovery (DAVID) v6.7. (Leidos Biomedical Research, Inc., Bethesda,
MD, USA).
Figure 5 Analysis of cell contact density in PC3 cells cultured with CM from PC3-MC3T3 co-culture systems. PC3 cells were treated or not with hemin (80 μM, 24 h) and then
co-cultured with or without MC3T3 cells (24 h), in different compartments (insert membrane and well). CM from the different experimental conditions was then added to PC3 cells
for 24 h. (a) Schematic representation of the experimental design. (b) Cells were fixed and stained with rhodamine–phalloidin and imaged by confocal microscopy to assess
contact density and number of protrusions (scale bars: 10 μm). One representative image for each group is shown. (c) Cell–Cell contact density versus cell–cell distance for all
treatments. For each area where two cells were in contact, the amount of contacts was obtained and a linear density was determined by computing the number of contacts per unit
perpendicular distance. Each data point represents the mean contact density within a bin determined by Freedman–Diaconis rule and error bars are the standard error of the
mean (N⩾ 37 contact regions per condition). (d) Boxplot comparing cell–cell contacts densities for the different experimental conditions. An intensity profile for each of these
sectors was determined using a custom made algorithm to count contacts (Matlab) (N⩾ 37 contact regions per condition; *Po0.001). (e) Boxplot comparing the measured
filopodia density per cell for the different experimental conditions. Error bars represent standard error (N⩾ 36 cells per condition; *Po0.001)
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Hemin pre-treatment of PCa cells and Co-culture system. An
in vitro bicompartment culture system was used as a model of bone metastases
from PCa as previously described slightly modified. Briefly cells were seeded
(100 000 cells) in cell culture inserts (0.4-mm pore; Falcon/Becton Dickinson
Labware, Franklin Lakes, NJ, USA) and on day 1 they were treated with hemin
(50 μM, Sigma-Aldrich, St. Louis, MO, USA), a potent inducer of HO-1 (PC3 Hem).
Controls received fresh medium. The MC3T3 cells were also seeded on day 1 in
tissue culture plates (100 000 cells per well). On day 2, the inserts containing the
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PC3 cells (pre-treated or not with hemin) were extensively washed with PBS.
Then, the inserts were placed into tissue culture plates containing MC3T3 so that
the two different cell types shared the culture medium but were not in
physical contact. Co-culturing of PC3 cells with MC3T3 was performed with
α-MEM plus 2% FBS for 24 h. As control, each cell type (PC3 cells and MC3T3
cells) was grown alone. On day 3, all CM were collected and used to incubate new
PC3 cells for 24 h so as to perform immunofluorescence and filopodia analysis on
day 4. Cultures were done in triplicate and each experiment was assayed
three times.
siRNA transfection. siRNA anti-HO-1 (siHO-1) was used to knock down
HO-1 expression and siRNA scramble was used as a negative control
(ON-TARGETplus siRNA reagents, both purchased at Dharmacon, Pittsburgh,
Pennsylvania, USA). The HO-1 siRNA is a pull of four targeted siRNA (HO-1 siRNA
cat# L-006372-00-05, scrambled siRNA cat# D-001810-01-05). In all, 1 × 106 PC3
cells were grown in 12-well plates until 60% confluence and then transfected using
Dharmacon (US) transfection reagent (Dharmacon) in medium supplemented with
10% FBS without antibodies. One day after transfection, the medium was replaced
for complete medium including or not hemin (80 μM, 24 h). Forty-eight hours after
transfection, cells were fixed and stained for immunofluorescence experiments.
Bioinformatics inference on protein–protein interactions. Refer-
ence amino-acid sequences for EEF1A1, GSN, HSPB1, LASP1, MEGF10, MKLN1,
MX1, NT5C2, RAI14, TES, TMOD3 (NP_001393.1, NP_001121135.2,
NP_001531.1, NP_006139.1, NP_115822.1, NP_037387.2, NP_001171517.1,
NP_001127845.1, NP_001138993.1, NP_056456.1, NP_055362.1, respectively)
were annotated from RefSeq and a search for similar protein structures was
achieved using Basic Alignment and Search Tool (BLAST) against the Protein Data
Bank (PDB). The resulting structures were selected by assessment of the alignment
coverage and score. Domain data were collected from the Protein Family database
(PFAM). HO-1 interactor candidate protein domains were annotated and searches
in the Interaction Protein Family (iPfam) database were performed, in order to get
structural description of domain–domain interactions. The information gathered from
these databases was used as input for the construction of an interaction network
using Cytoscape 3.2.1 software.
Bioinformatics analysis
Information source and eligibility criteria (Oncomine): We searched the
public cancer microarray database, Oncomine (715 data sets investigating and 68
tumor types), to identify expression microarray data sets that compared the
expression of prostate adenocarcinoma versus prostate gland. In order to be
included in our study, a data set was required to (1) be generated from human
tumors, (2) compare prostate adenocarcinoma versus prostate gland, (3) have a P-
value o0.05 and (4) have a fold change 41.5 and/or (5) have a gene rank
between 1 and 10%. It is worth mentioning that although the P-value criteria was
strict for the data set selection, some genes were considered even if the fold change
or the gene rank was o1.5% or 410%, respectively, when the gene showed a
significant over or under expression.
Search/study selection (Oncomine): We performed one search for each
gene using the 'gene symbol' as the search term and obtained different number of
studies for each gene. The selected studies were analyzed on the basis of normal
gland versus prostate adenocarcinoma. Cited literature was reviewed to confirm that
the analysis was as documented in the Oncomine database.
Data source and selection criteria (CBioPortal): The cBio Cancer
Genomics Portal (http:/cbioportal.org), (open source cancer genomics data platform
created by Memorial Sloan-Kettering Cancer Center (MSKCC)) was used to analyze
the most common mutations of the selected genes in PCa. The criteria used in
order to include data sets in our analysis were the following: (1) type of cancer:
PCa; (2) the study must be published and (3) the study must consist of 460
samples.
Immunofluorescence experiments and quantitative microscopy: PC3
cells were fixed with 8% paraformaldehyde (PFA) (20 min, room temperature) and
stained with rhodamine–phalloidin (1 h, room temperature). Confocal images were
acquired by confocal microscopy (FV1000, Olympus, Tokyo, Japan) using an
UPlanSApo 60x oil immersion objective (NA 1/41.35; Olympus), a diode laser of
543 nm as the excitation source and fluorescence was collected in the range of
555–655 nm. We selected the regions from which filopodia from two neighboring
cells were in contact, considered as 'contacts', and divided these regions into
segments where the distance between the cells remained constant. An intensity
profile for each of these areas was analyzed with a custom made Matlab algorithm
to count contacts. A 'contact density' was defined for each region as the ratio
between the number of contacts and the length of the profile.
To determine the distance to the first neighbor, cells were fixed with PFA8% and
stained with C-Laurdan. Wide field fluorescence images were acquired using
an Olympus IX71 inverted epifluorescence microscope, with an UPlanSApo 10x
objective (NA 0.30, Olympus). The images were obtained using a Qimaging EXI
Aqua camera. The images were analyzed with an algorithm designed to binnarize
the image and assign a label to each set of connected pixels. Every set of connected
pixels represents a single cell in most cases and a cell cluster when the binnari-
zation process could not distinguish among cells in contact or too close to each other.
For every cell–cell cluster, the distance to all the other cell–cell clusters was
calculated and to the first neighbor cell. Distances were normalized to the average cell
radius.
Microtubule mechanics in PC3 cells was evaluated using confocal micro-
scopy. Cells were treated with a primary antibody against tubulin and secondary
antibody conjugated with Alexa-647. The effective Lp of microtubules in PC3 cells
was determined using the methodology described by Gittes et al.,37 for cells
treated or not with hemin. Briefly, microtubule xy positions were recovered using a
filament tracking routine,38 a Fourier analysis was performed on the shape of the
filaments and mode amplitudes were recorded. Finally, Lp* was obtained by fitting an
inverse square law to the ensemble variance of these amplitudes as a function of the
mode number.
Image processing for presentation: Confocal and wide field microscope
images were processed for presentation using ImageJ software (NIH, Bethesda,
MD, USA). Background of each channel was subtracted and in some cases a
median filter (radius: 1 pixel) was applied only for presentation.
Immunoblotting: PC3 cells were lysed with CelLytic M Cell Lysis Reagent
(Sigma-Aldrich, UK), incubated on ice for 20 min, centrifuged at 12 000 r.p.m. for
3 min and the supernatant was collected. Protein concentration was determined
using the bicinchoninic acid (BCA) protein assay kit from (Sigma-Aldrich, UK).
Samples were then resolved by SDS-PAGE, transferred to a nitrocellulose
membrane (Invitrogen). Membranes were blocked for 1 h with 5% (w/v) non-fat milk
in TBS-T buffer (0.1% Tween-20 in 10 mM Tris-HCl pH 7.4), and then incubated with
Figure 6 Analysis of RNAseq data of PCa cells overexpressing HO-1 pharmacologically or genetically. (a) RNAseq heat map of PC3 cells overexpressing HO-1
pharmacologically (Hemin) or genetically (PC3HO-1) and their respective controls. The transcripts were clustered in a conventional heat map analysis with red, blue and white
plots representing transcripts with greater, intermediate and lower number of counts, respectively. (b) Schematic representation indicating the number and subset of upregulated
(⩾2,⩾ 3,⩾ 5,⩾ 8 PC3HO-1-red circles; PC3 hemin-yellow circles) and downregulated genes (⩽−2,⩽− 3,⩽− 5,⩽− 8, PC3HO-1-green circles; PC3 hemin-blue circles). The
circle intersections show the number of overlapping genes between both conditions. (c) Functional analyses of differentially expressed genes by DAVID (https://david.ncifcrf.gov/).
GO analysis on twofold-regulated overlapping genes between both conditions. The resulting categories were further sub-clustered into two global categories named: 'cytoskeletal,
cell adhesion and homeostasis categories' (yellow) and 'other function' (green). (d) Heat map for the twofold overlapping differentially expressed genes for cytoskeletal-associated
GO categories and other pathways relevant to cell adhesion. Red, blue and white plots represent transcripts with greater, intermediate and lower number of counts, respectively.
Genes associated specifically with cell adhesion and cell–cell communication are marked in blue and light blue respectively. (e) Gene interaction network between the twofold
overlapping HO-1 upregulated (red) and downregulated (blue) GO categories. Interconnectivity is depicted either by genetic interactions (green lines), physical interactions (red
lines) or common pathways (turquoise lines)
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specific primary antibodies overnight at 4 oC: anti-HO-1 (1 : 1000), anti-β-actin
(1 : 4000). The next day, the membranes were incubated with secondary antibodies
for 1 h at room temperature. Protein bands were detected using ECL reagents
(Amersham Ltd).
Cell tracking: Cells were seeded in 35 mm Petri dishes and cultured until
confluence. The cells were then scraped with a 200 μl micropipette tip, denuding a
strip of the monolayer and placed onto a Zeiss Axio Observer Microscope (Zeiss,
Germany) equipped with an incubation chamber (ibidi Heating System, Ibidi,
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Germany) set at 37 oC. Phase contrast images were taken every 20 min during 48 h
using a camera AxioCam HRm from Zeiss. The movies were processed using the cell
tracking plug-in from Fiji (http://fiji.sc/Fiji) to extract cell trajectories and analyzed to
obtain the MSD following equation 1, where x and y are the coordinates of the particle, t
is time, and the brackets represent the trajectories ensamble average (see equation 1).
MSDðtÞ ¼oðxðtÞ  xð0ÞÞ42þ ðyðtÞ  yð0ÞÞ42 > ð1Þ
Statistical analysis. Results are shown as mean± s.e.m of ‘n’ separate
independent experiments unless otherwise is stated. In cases were binning was
required, the size of the bins was determined by Freedman–Diaconi's rule. Boxplots
show mean, median and whiskers represent the 5–95% window. For the distance
analysis to the first neighboring cell, distributions were compared with a two-sample
Kolmogorov–Smirnov test. A kernel smoothing density estimate was applied to the
data in order to obtain probability density estimate curves.
RNA sequencing. The sequencing libraries for the RNA samples were
prepared with the TruSeq Stranded Total RNA kit (Illumina Inc., San Diego, CA,
USA), from 1 μg total RNA. Following the manufacturer’s instructions, the first step
depleted rRNA from total RNA. After ribosomal depletion, the remaining RNA was
purified, fragmented and primed for cDNA synthesis. Fragmented RNA was then
reverse transcribed into first-strand cDNA using random primers. The next step
removed the RNA template and synthesized a replacement strand, incorporating
dUTP in place of dTTP to generate ds cDNA. AMPure XP beads were used to
separate the ds cDNA from the second strand reaction mix resulting in blunt-ended
cDNA. A single ‘A’ nucleotide was then added to the 3’ ends of the blunt fragments.
Multiple indexing adapters, containing a single ‘T’ nucleotide on the 3’ end of the
adapter, were ligated to the ends of the ds cDNA, preparing them for hybridization
onto a flow cell. Libraries were purified and validated for appropriate size on a 2100
Bioanalyzer High Sensitivity DNA chip (Agilent Technologies, Inc., Santa Clara, CA,
USA). The DNA library was quantitated using Kapa Biosystems qPCR kit
(Wilmington, MA, USA), and then pooled together in an equimolar manner to a final
concentration of 2 nM, following experimental design criteria. Each pool was
denatured, diluted to 10pM, and clustered to individual lanes of a HiSeq Flow Cell
using an Illumina cBot and the corresponding paired-end TruSeq V3 cluster kit.
Pooled, clustered samples were then run on a HiSeq2500 sequencer according to
the manufacturer's recommended protocol (Illumina Inc.).
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